Genetic risk analysis of a patient with fulminant autoimmune type 1 diabetes mellitus secondary to combination ipilimumab and nivolumab immunotherapy

Overview of attention for article published in Journal for Immunotherapy of Cancer, December 2016

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

patent: 1 patent

Citations

dimensions_citation: 88 Dimensions

Readers on

mendeley: 79 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

MARKERS FOR IDENTIFYING PATIENT CLASSES AND USE THEREOF

Application WO-2018084706-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.